Frontlight ResearchEarly access
Trial site
Q&T Research Sherbrooke Inc.
- 3running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease4 trials
- Mild cognitive impairment1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 35 trials
- Status
- Active, not recruiting3 trials
- Completed1 trial
- Suspended1 trial
- Lead sponsor
- Eli Lilly and Company2 trials
- Eisai Inc.1 trial
- Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 trial
- Novo Nordisk A/S1 trial
Running trials
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026